662 filings
Page 3 of 34
3
OCUP
Ocuphire Pharma Inc
3 Nov 23
Ocuphire Pharma / George Magrath ownership change
9:22am
8-K
OCUP
Ocuphire Pharma Inc
2 Nov 23
Ocuphire Corporate Presentation November 2023
8:44am
8-K
OCUP
Ocuphire Pharma Inc
1 Nov 23
Ocuphire Pharma Announces Appointment of George Magrath, M.D., M.B.A., M.S., as Chief Executive Officer and Director
4:21pm
8-K
OCUP
Ocuphire Pharma Inc
27 Sep 23
RYZUMVI Expected to be Commercially Available in the U.S. in the First Half of 2024
8:45am
424B5
OCUP
Ocuphire Pharma Inc
14 Aug 23
Prospectus supplement for primary offering
8:00am
8-K
OCUP
Ocuphire Pharma Inc
11 Aug 23
Ocuphire Pharma Announces Financial Results for Second Quarter 2023 and Provides Corporate Update
9:27am
10-Q
2023 Q2
OCUP
Ocuphire Pharma Inc
Quarterly report
11 Aug 23
8:51am
8-K
OCUP
Ocuphire Pharma Inc
1 Aug 23
Restore Vision & Clarity Ocuphire Corporate Presentation August 2023
11:21am
UPLOAD
OCUP
Ocuphire Pharma Inc
12 Jul 23
Letter from SEC
12:00am
CORRESP
OCUP
Ocuphire Pharma Inc
7 Jul 23
Correspondence with SEC
12:00am
UPLOAD
OCUP
Ocuphire Pharma Inc
28 Jun 23
Letter from SEC
12:00am
8-K
OCUP
Ocuphire Pharma Inc
14 Jun 23
Departure of Directors or Certain Officers
4:31pm
4
Sean Ainsworth
8 Jun 23
Ocuphire Pharma / Sean Ainsworth ownership change
6:49pm
4
James S J Manuso
8 Jun 23
Ocuphire Pharma / JAMES S J MANUSO ownership change
6:49pm
4
OCUP
Ocuphire Pharma Inc
8 Jun 23
Ocuphire Pharma / Jay Pepose ownership change
6:49pm
4
OCUP
Ocuphire Pharma Inc
8 Jun 23
Ocuphire Pharma / Susan Benton ownership change
6:48pm
4
Cam Gallagher
8 Jun 23
Ocuphire Pharma / Cam Gallagher ownership change
6:48pm
8-K
OCUP
Ocuphire Pharma Inc
8 Jun 23
Submission of Matters to a Vote of Security Holders
5:58pm
8-K
OCUP
Ocuphire Pharma Inc
2 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:30pm
10-Q
2023 Q1
OCUP
Ocuphire Pharma Inc
Quarterly report
15 May 23
8:20am